Back
Anheuser-Busch InBev SA/NV Vs. Novo Nordisk AS Industry Stock Comparison
Buy
58
BUDFF
Anheuser-Busch InBev SA/NV
Last Price:
$62.22
Seasonality Move:
0.87%
Sell
30
NONOF
Novo Nordisk AS
Last Price:
$74.16
Seasonality Move:
4.87%
Buy
58
Anheuser-Busch InBev SA/NV (BUDFF)
is a Buy
Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?
-
The current Anheuser-Busch InBev SA/NV [BUDFF] share price is $62.02. The Score for BUDFF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
BUDFF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $79.09. The Score for NONOF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BUDFF Stock Price Chart
What is Anheuser-Busch InBev SA/NV's stock price today?
-
The Anheuser-Busch InBev SA/NV share price today is $62.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BUDFF is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $79.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
BUDFF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.25 | Buy |
Relative Strength Index (14 RSI): | 77.81 | Buy |
Chaikin Money Flow: | -2053 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.03 - 59.89) | Buy |
Bollinger Bands (100): | (49.04 - 60.4) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 38.5 | Sell |
Chaikin Money Flow: | 404837 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.79 - 89.61) | Sell |
Bollinger Bands (100): | (83.94 - 109.78) | Sell |
BUDFF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.34 | Buy |
20-day SMA: | 56.37 | Buy |
50-day SMA: | 51.9 | Buy |
200-day SMA: | 58.31 | Buy |
8-day EMA: | 60.93 | Buy |
20-day EMA: | 57.46 | Buy |
50-day EMA: | 54.54 | Buy |
200-day EMA: | 56.83 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.84 | Sell |
20-day SMA: | 85.93 | Sell |
50-day SMA: | 85.07 | Sell |
200-day SMA: | 115.26 | Sell |
8-day EMA: | 86.5 | Sell |
20-day EMA: | 86.55 | Sell |
50-day EMA: | 88.81 | Sell |
200-day EMA: | 104.91 | Sell |
Anheuser-Busch InBev SA/NV Earnings Growth & BUDFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Anheuser-Busch InBev SA/NV Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |